Mitsubishi UFJ Asset Management’s Pacira BioSciences PCRX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$191K	Buy	7,509 +7,337	+4,266%	+$173K	﹤0.01%	1024
2026 Q1	$3.89K	Hold	172	–	–	﹤0.01%	1532
2025 Q4	$4.21K	Hold	172	–	–	﹤0.01%	1513
2025 Q3	$4.43K	Hold	172	–	–	﹤0.01%	1479
2025 Q2	$4.11K	Hold	172	–	–	﹤0.01%	1503
2025 Q1	$4.27K	Hold	172	–	–	﹤0.01%	1477
2024 Q4	$3.17K	Hold	172	–	–	﹤0.01%	1536
2024 Q3	$2.59K	Hold	172	–	–	﹤0.01%	1558
2024 Q2	$4.92K	Sell	172 -6,177	-97%	-$176K	﹤0.01%	1377
2024 Q1	$186K	Sell	6,349 -283	-4%	-$8.69K	﹤0.01%	967
2023 Q4	$213K	Buy	6,632 +1,529	+30%	+$44.7K	﹤0.01%	1004
2023 Q3	$157K	Buy	5,103 +438	+9%	+$15.8K	﹤0.01%	1045
2023 Q2	$187K	Buy	4,665 +513	+12%	+$21.2K	﹤0.01%	1048
2023 Q1	$169K	Buy	4,152 +401	+11%	+$16K	﹤0.01%	1041
2022 Q4	$146K	Buy	3,751 +821	+28%	+$39.9K	﹤0.01%	1057
2022 Q3	$156K	Buy	2,930 +203	+7%	+$11.3K	﹤0.01%	1054
2022 Q2	$159K	Sell	2,727 -1,380	-34%	-$90.4K	﹤0.01%	1066
2022 Q1	$313K	Buy	4,107 +255	+7%	+$17K	﹤0.01%	994
2021 Q4	$236K	Buy	+3,852	New	+$212K	﹤0.01%	1057

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mitsubishi UFJ Asset Management's PCRX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Pacira BioSciences (PCRX) stake by 4,266% in Q2 2026, buying an estimated $173K and bringing the position to 7,509 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Mitsubishi UFJ Asset Management first reported a position in PCRX in Q4 2021 and has held it in 19 quarters since. The position peaked at $313K in Q1 2022. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Mitsubishi UFJ Asset Management held 7,509 shares of Pacira BioSciences worth $191K as of Q2 2026.
Mitsubishi UFJ Asset Management bought 7,337 Pacira BioSciences shares in Q2 2026, an estimated $173K.
Pacira BioSciences made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1024 holding.
Mitsubishi UFJ Asset Management first reported a position in Pacira BioSciences in Q4 2021 and has held it in 19 quarters since.
Mitsubishi UFJ Asset Management's Pacira BioSciences position peaked at $313K in Q1 2022.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.